Literature DB >> 18158480

Cardiogenic shock.

Simon Topalian1, Fredric Ginsberg, Joseph E Parrillo.   

Abstract

Cardiogenic shock is the most common cause of death in patients hospitalized with acute myocardial infarction and is associated with a poor prognosis. More than 75% of cases are due to extensive left ventricular infarction and ventricular failure. Other causes include right ventricular infarction and papillary muscle rupture with acute severe mitral regurgitation. Activation of neurohormonal systems and the systemic inflammatory response worsens shock. To improve outcomes, cardiogenic shock needs to be recognized early in its course and its cause needs to be diagnosed rapidly. Treatment strategies using intra-aortic balloon counterpulsation and emergency revascularization by percutaneous coronary interventions or coronary bypass surgery have been shown to improve outcomes. To decrease the incidence of cardiogenic shock, public education regarding early presentation to hospital in the course of acute chest pain is important. Emergency medical transport systems may need to take patients with complicated acute myocardial infarction to hospitals with the capability to perform urgent revascularization.

Entities:  

Mesh:

Year:  2008        PMID: 18158480     DOI: 10.1097/01.CCM.0000296268.57993.90

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Antifungal proteins: targets, mechanisms and prospective applications.

Authors:  T Theis; U Stahl
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

2.  Chinese guidelines for diagnosis and treatment of influenza (2011).

Authors:  Nan-Shan Zhong; Yi-Min Li; Zi-Feng Yang; Chen Wang; You-Ning Liu; Xing-Wang Li; Yue-Long Shu; Guang-Fa Wang; Zhan-Cheng Gao; Guo-Hua Deng; Li-Xian He; Xiu-Ming Xi; Bin Cao; Kun-Ling Shen; Hao Wu; Ping-An Zhou; Qing-Quan Li
Journal:  J Thorac Dis       Date:  2011-12       Impact factor: 2.895

3.  [Angiopoietin-2: prognostic parameter in cardiogenic shock].

Authors:  A Link
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-02       Impact factor: 0.840

Review 4.  Mechanical circulatory support in acute heart failure.

Authors:  Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2012

Review 5.  [Cardiogenic shock].

Authors:  S Rasche; C Georgi
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

6.  [Heart rate and rate control : Prognostic value in cardiovascular diseases].

Authors:  F Custodis; J-C Reil; U Laufs; M Böhm
Journal:  Internist (Berl)       Date:  2012-01       Impact factor: 0.743

Review 7.  [Ivabradine - a new therapeutic option for cardiogenic shock?].

Authors:  Felix Post; Thomas Münzel
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

8.  [Cardiogenic shock].

Authors:  S Rasche; C Georgi
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

9.  Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients.

Authors:  Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Reinhard Kitzberger; Joanna Warszawska; Ulrike Holzinger; Peter Schenk; Christian Madl
Journal:  Intensive Care Med       Date:  2009-06-09       Impact factor: 17.440

Review 10.  Water and sodium in heart failure: a spotlight on congestion.

Authors:  Gaspare Parrinello; Stephen J Greene; Daniele Torres; Michael Alderman; Joseph Vincent Bonventre; Pietro Di Pasquale; Luna Gargani; Anju Nohria; Gregg C Fonarow; Muthiah Vaduganathan; Javed Butler; Salvatore Paterna; Lynne Warner Stevenson; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.